Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29779783 | 1.00 | TAAR1 (0.50) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL8073131 | 0.94 | TAAR1 (0.48) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL9241987 | 0.92 | TAAR1 (0.47) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL8070767 | 0.92 | TAAR1 (0.47) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL8077854 | 0.92 | TAAR1 (0.47) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL8078262 | 0.92 | TAAR1 (0.47) | TAAR1TLR8CHRM2GPR84ALDH1A1 | |
| SCHEMBL9244061 | 0.88 | HDAC1 (0.43) | TAAR1TLR8ALDH1A1USP2HPGD | |
| SCHEMBL1240981 | 0.88 | TAAR1 (0.54) | TAAR1CHRM2GPR84ALDH1A1DAO | |
| SCHEMBL2098064 | 0.86 | TAAR1 (0.52) | TAAR1CHRM2GPR84ALDH1A1DAO | |
| SCHEMBL10430495 | 0.86 | TAAR1 (0.52) | TAAR1CHRM2GPR84ALDH1A1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102300550-A | Perfume systems | — | 2011-12-28 | — | — | CN | claimed |
| US-7935856-B2 | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | HYOSUNG CORPORATION (KR) | 2011-05-03 | — | — | US | claimed |
| CN-100584810-C | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | HYOSUNG CORP | 2010-01-27 | — | — | CN | claimed |
| EP-1849758-B1 | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | HYOSUNG CORP (KR) | 2009-03-25 | — | — | EP | claimed |
| EP-1849758-A1 | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | Hyosung Corporation (KR) | 2007-10-31 | — | — | EP | claimed |
| CN-101050161-A | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | HYOSUNG CORP (KR) | 2007-10-10 | — | — | CN | claimed |
| US-20070232842-A1 | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | HYOSUNG CORPORATION (KR) | 2007-10-04 | — | — | US | claimed |
| WO-2004058666-A1 | PREPARATION METHOD OF 1,5-DIMETHYLTETRALIN | HYOSUNG CORPORATION (KR) | 2004-07-15 | — | — | WO | claimed |
| EP-0926114-B1 | Crystallization of 2,6-Dimethylnaphthalene | BP CORP NORTH AMERICA INC (US) | 2004-05-19 | — | — | EP | claimed |
| EP-1368297-A2 | SYNTHESIS AND USE OF DIMETHYL-1,5-NAPHTHALENEDICARBOXYLATES AND INTERMEDIATES THEREFROM | BP Corporation North America Inc. (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0687248-A4 | CRYSTALLIZATION OF 2,6-DIMETHYLNAPHTHALENE | AMOCO CORP (US) | 1996-05-01 | — | — | EP | claimed |
| US-5510563-A | ALKENYLATION, CYCLIZATION, DEHYDROGENATION, AND ISOMERIZATION | AMOCO CORPORATION (US) | 1996-04-23 | — | — | US | claimed |
| EP-0687248-A1 | CRYSTALLIZATION OF 2,6-DIMETHYLNAPHTHALENE | AMOCO CORPORATION (US) | 1995-12-20 | — | — | EP | claimed |
| WO-1995018086-A1 | CRYSTALLIZATION OF 2,6-DIMETHYLNAPHTHALENE | AMOCO CORPORATION (US) | 1995-07-06 | — | — | WO | claimed |
| EP-0461913-B1 | Catalytic alkenylbenzene cyclization | AMOCO CORP (US) | 1995-02-22 | — | — | EP | claimed |
| US-5365001-A | Catalytic cyclization of alkenebenzene in the presence of hydrogen | TEIJIN LIMITED (JP) | 1994-11-15 | — | — | US | claimed |
| EP-0594856-A1 | PROCESS FOR PRODUCING DIALKYLNAPHTHALENE | TEIJIN LIMITED (JP) | 1994-05-04 | — | — | EP | claimed |
| EP-0461913-A2 | Catalytic alkenylbenzene cyclization | AMOCO CORPORATION (US) | 1991-12-18 | — | — | EP | claimed |
| US-5034561-A | Formation of dialkyltetrahydronaphthalene in the presence of a zeolite catalyst | AMOCO CORPORATION (US) | 1991-07-23 | — | — | US | claimed |
| US-4740647-A | COPPER ALUMINUM BORATE TO CATALYZE DEHYDROCYCLIZATION OF ALKENYL AROMATIC COMPOUND | AMOCO CORPORATION (US) | 1988-04-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232842-A1 | Preparation method of 1,5-dimethyltetralin using dealuminated zeolite beta catalyst | DERA, DIMT1, MGST1 | TAAR1 893/4885TLR8 4023/4885CHRM2 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.